hansoh pharma merck news - Search News

Merck reaches weight-loss drug deal worth up to $2 billion

Reuters on MSN · 18h

Merck signs deal worth up to $2 billion with China's Hansoh for oral obesity drug

Merck on Wednesday signed a deal worth up to $2 billion with Hansoh Pharma to develop and sell the Chinese biotech's experimental oral obesity drug that works similar to the popular weight-loss treatments Wegovy and Zepbound.

Seeking Alpha on MSN · 19h

Merck enters obesity drug race in pact with Chinese pharma Hansoh

Merck (NYSE:MRK) and Chinese biopharmaceutical company Hansoh Pharma (OTCPK:HNSPF) announced a global licensing deal on Wednesday to develop HS-10535, an oral GLP-1 receptor agonist targeted at weight loss and other cardio metabolic conditions.

UPI News on MSN · 12h

Merck reaches weight-loss drug deal worth up to $2 billion with China-based Hansoh

Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named HS-10535. It includes a $112 million licensing rights payment for global sales outside China.

FierceBiotech20h

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh's preclinical drug

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...

18h

What's Going On With Merck Shares Wednesday?

Merck & Company Inc (NYSE:MRK) shares are trading higher. The company on Wednesday announced a GLP-1 agreement with Chinese ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results